Free Trial

VSee Health (VSEE) Competitors

VSee Health logo
$1.05 -0.07 (-6.25%)
As of 02:06 PM Eastern

VSEE vs. BRTX, MGRX, SSY, OTRK, BGLC, ATIP, ACON, DHAC, NIVF, and BACK

Should you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), Aclarion (ACON), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry.

VSee Health vs. Its Competitors

VSee Health (NASDAQ:VSEE) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, community ranking, media sentiment, dividends, risk, profitability and institutional ownership.

1.0% of VSee Health shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 6.6% of VSee Health shares are held by insiders. Comparatively, 25.5% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

VSee Health has higher revenue and earnings than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VSee Health$6.38M0.59-$4.41MN/AN/A
Biorestorative Therapies$400K31.50-$8.98M-$1.47-1.14

VSee Health and Biorestorative Therapies both received 2 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
VSee HealthOutperform Votes
2
100.00%
Underperform Votes
No Votes
Biorestorative TherapiesOutperform Votes
2
100.00%
Underperform Votes
No Votes

VSee Health currently has a consensus price target of $5.00, indicating a potential upside of 376.19%. Biorestorative Therapies has a consensus price target of $18.00, indicating a potential upside of 971.43%. Given Biorestorative Therapies' higher possible upside, analysts plainly believe Biorestorative Therapies is more favorable than VSee Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VSee Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Biorestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

VSee Health has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. Biorestorative Therapies' return on equity of -129.47% beat VSee Health's return on equity.

Company Net Margins Return on Equity Return on Assets
VSee HealthN/A -182.59% -58.26%
Biorestorative Therapies -3,093.61%-129.47%-86.02%

In the previous week, Biorestorative Therapies had 2 more articles in the media than VSee Health. MarketBeat recorded 3 mentions for Biorestorative Therapies and 1 mentions for VSee Health. Biorestorative Therapies' average media sentiment score of 0.50 beat VSee Health's score of 0.00 indicating that Biorestorative Therapies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
VSee Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Biorestorative Therapies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Biorestorative Therapies beats VSee Health on 8 of the 14 factors compared between the two stocks.

Get VSee Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VSEE vs. The Competition

MetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ Exchange
Market Cap$3.78M$18.05B$26.98B$8.72B
Dividend YieldN/A2.62%2.96%4.23%
P/E RatioN/A65.4635.2019.48
Price / Sales0.5964.592,830.11109.45
Price / CashN/A82.4633.0226.73
Price / Book-0.318.426.905.75
Net Income-$4.41M$334.48M$776.75M$248.52M
7 Day Performance1.94%1.42%1.71%2.09%
1 Month Performance-3.67%1.62%5.17%5.54%
1 Year PerformanceN/A58.11%52,247.94%16.58%

VSee Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VSEE
VSee Health
1.6188 of 5 stars
$1.05
-6.3%
$5.00
+376.2%
N/A$3.78M$6.38M0.00N/ANews Coverage
BRTX
BioRestorative Therapies
3.75 of 5 stars
$1.72
+6.2%
$18.00
+946.5%
-19.2%$12.83M$391K-1.127Buyback Announcement
MGRX
Mangoceuticals
0.3882 of 5 stars
$1.97
+2.3%
N/A-97.6%$10.16M$511.08K-0.343Gap Up
SSY
SunLink Health Systems
1.9249 of 5 stars
$0.98
-0.4%
N/A+63.7%$6.89M$31.09M6.991,376News Coverage
Negative News
OTRK
Ontrak
2.2163 of 5 stars
$1.41
-1.1%
$45.00
+3,102.8%
-60.2%$5.93M$10.18M-0.13250News Coverage
BGLC
BioNexus Gene Lab
0.1275 of 5 stars
$2.92
-1.9%
N/A-40.8%$5.24M$9.27M0.0030News Coverage
Positive News
ATIP
ATI Physical Therapy
N/A$1.04
+0.6%
N/A-82.7%$4.57M$741.86M-0.065,600
ACON
Aclarion
2.9212 of 5 stars
$7.47
+2.3%
$11,758.50
+157,415.1%
-99.7%$4.35M$54.60K0.007News Coverage
DHAC
Digital Health Acquisition
N/A$1.06
+5.0%
N/A-90.6%$3.82MN/A0.002,021
NIVF
NewGenIvf Group
N/A$1.28
-7.6%
N/A-99.5%$672K$5.43M0.00N/APositive News
BACK
IMAC
N/A$0.04
+3.1%
N/A-97.6%$91K$72.05K0.00180

Related Companies and Tools


This page (NASDAQ:VSEE) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners